Table S3. Genes differentially expressed in GFP? CD133+ compared with GFP+ CD133+ and GFP? CD133? dermal cells

Supplementary Table 1. ‘‘Neurogenic Neural Progenitors (nNPs) group’’–Expression level on day 3 (3+ and/or 3++) is at least twice higher than expression in earlier time points (days 0 and 1), with expression level at day 8 being equal or higher than at day 3 (day (3++))

Supplementary Table 1. ‘‘Embryonic Stem (ES) cells group’’–Expression level on day 0 is at least twice higher than expression in all other time points (days 1, 3 and 8)

Supplementary Table 1. ‘‘Transient Neural Progenitors (tNPs) group’’–Expression level on day 3 is at least twice higher than expression in all other time points (days 0, 1 and 8)

Supplementary Table 1. ‘‘Primitive Ectoderm (PE) group’’–Expression level on day 1 is at least twice higher than expression in all other time points (days 0, 3 and 8);

Supplementary Table 1. ‘‘Rosette group’’ - Expression level on day 8 is at least twice higher than expression in all other time points (days 0, 1 and 3); in addition, expression levels at day 0, 1 and 3 cannot increase more than twice between them

Table S6. Genes that are repressed in nave  memory  cord blood cells relative to centroblasts and centrocytes in the dataset of Basso et al. (Nature Genet 2005) (XLS  176 KB)

Table 2. Differentially expressed genes between control (n = 10) and trained (n = 10) rat groups.

Additional file 2. Full list of the 300 most expressed genes independent of the rat group (TRA AND CTR)

Table 1. Sixty-One Genes Differentially Expressed Between Benign  Borderline  and/or Malignant Thyroid Lesions

Table S9B Comparison of genes upregulated in enriched cardiomyocytes (CM vs EB) identified by 2 studies (Cao et al  and this study) (ND: not detected as being up-regulated in percoll gradient enriched Cardiomyocytes by Cao et al)

Table S3: Genes more than 2-fold up-regulation in hESC derived enriched cardiomyocytes (CM) compared with ES and EB; Fold change is caculated as mean of 3 replicates